OpenVSafe by OpenVAERS
Search V-safe

8QB-36179-07395

3 vaccinations 4 coded responses 14 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
018 / MA
Registered
2022-02-26
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-07
    Dose 1 — Pfizer-BioNTech
  2. 2021-05-08
    Dose 2 — Pfizer-BioNTech
  3. 2022-02-24
    Dose 3 — Pfizer-BioNTech
  4. 2022-02-26
    Registered in v-safe
  5. 2022-02-26
    Survey response — days 1–6 daily, dose 3
    MedDRA: Oedema peripheral — Feeling: Poor · Site: Swelling · Be unable to do your normal daily activities
    Free text: Swelling in armpits
    MedDRA releases: 2024-11 · check-in free text available
  6. 2022-02-27
    Survey response — days 1–6 daily, dose 3
    MedDRA: Joint swelling, Oedema peripheral — Feeling: Poor · Site: Pain, Swelling · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Swelling in both armpits and behind the knee
    MedDRA releases: 2024-11 · check-in free text available
  7. 2022-02-28
    Survey response — days 1–6 daily, dose 3
    MedDRA: Oedema peripheral — Feeling: Fair · Site: Pain, Swelling
    Free text: Swelling in armpits
    MedDRA releases: 2024-11 · check-in free text available
  8. 2022-03-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · None
    Adult check-in
  9. 2022-03-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  10. 2022-03-03
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  11. 2022-03-11
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  12. 2022-03-17
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  13. 2022-03-24
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  14. 2022-03-31
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  15. 2022-04-07
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  16. 2022-05-27
    Survey response — 3 months, dose 3
    MedDRA: Headache, Nasal congestion, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Nasal congestion, stuffy nose, runny nose, headache
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-08-25
    Health check-in — 6 months, dose 3
    Feeling: Poor
    Adult check-in
  18. 2023-02-24
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-07Pfizer-BioNTech No
22021-05-08Pfizer-BioNTech No
32022-02-24Pfizer-BioNTech No

Free text

Release 11 — days 1–6 daily, dose 3

2022-02-26

Systemic reaction (other): Swelling in armpits

2022-02-27

Systemic reaction (other): Swelling in both armpits and behind the knee

2022-02-28

Systemic reaction (other): Swelling in armpits

Release 11 — 3 months, dose 3

2022-05-27

Symptoms: Nasal congestion, stuffy nose, runny nose, headache

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHeadache · · ✓
SDNasal congestion · · ✓
SDRhinorrhoea · · ✓
SROJoint swelling · · ✓
SROOedema peripheral · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release